Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Effect of Add-on Pentoxifylline Therapy on Proteinuria and eGFR in Membranous Glomerulonephritis: A 6-Month Randomized Placebo-Controlled Trial

  • In: SIG Posters
  • At: Amsterdam (the Netherlands) (2012)
  • Type: Poster
  • Poster code: TRI-03
  • By: BADRI, Shirinsadat (Tehran University of Medical Sciences, Department of Clinical Pharmacy, Tehran, Iran)
  • Co-author(s): Dashti-Khavidaki, S. (Tehran University of Medical Sciences, Tehran, Iran)
    Ahmadi, F. (Tehran University of Medical Sciences, Tehran, Iran)
    Mahdavi-Mazdeh, M. (Tehran University of Medical Sciences, Tehran, Iran)
    Abbasi, M.R. (Tehran University of Medical Sciences, Tehran, Iran)
  • Abstract:


    Background:

    Membranous glomerulonephritis (MGN) may have proteinuria as the main complication and strong risk factor to reach end-stage renal disease. Current therapeutic regimens provide only partial renoprotection. Data derived from both animal and human studies provide a scientific basis for the use of pentoxifylline (PTF) as an

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses